Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients. (AMIRST)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2013 by TotipotentRX Cell Therapy Pvt. Ltd..
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborator:
TotipotentRX Corporation
Information provided by (Responsible Party):
TotipotentRX Cell Therapy Pvt. Ltd.
ClinicalTrials.gov Identifier:
NCT01536106
First received: July 16, 2011
Last updated: September 3, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Publications: